Encompass Health Corporation (NYSE: EHC) Stock Competitors & Peer Comparison

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while HCA trades at $405.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas HCA's P/E ratio is 13.99. In terms of profitability, EHC's ROE is +0.25%, compared to HCA's ROE of -1.13%. Regarding short-term risk, EHC is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check HCA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while THC trades at $265.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas THC's P/E ratio is 15.37. In terms of profitability, EHC's ROE is +0.25%, compared to THC's ROE of +0.51%. Regarding short-term risk, EHC is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for EHC.Check THC's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while FMS trades at $22.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas FMS's P/E ratio is 8.52. In terms of profitability, EHC's ROE is +0.25%, compared to FMS's ROE of +0.07%. Regarding short-term risk, EHC is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check FMS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while DVA trades at $183.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas DVA's P/E ratio is 14.37. In terms of profitability, EHC's ROE is +0.25%, compared to DVA's ROE of -1.24%. Regarding short-term risk, EHC is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check DVA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while UHS trades at $169.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas UHS's P/E ratio is 7.53. In terms of profitability, EHC's ROE is +0.25%, compared to UHS's ROE of +0.21%. Regarding short-term risk, EHC is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check UHS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ENSG trades at $170.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ENSG's P/E ratio is 24.75. In terms of profitability, EHC's ROE is +0.25%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, EHC is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ENSG's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while OSH trades at $39.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas OSH's P/E ratio is -17.65. In terms of profitability, EHC's ROE is +0.25%, compared to OSH's ROE of +4.64%. Regarding short-term risk, EHC is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for EHC.Check OSH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CHE trades at $519.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CHE's P/E ratio is 24.08. In terms of profitability, EHC's ROE is +0.25%, compared to CHE's ROE of +0.29%. Regarding short-term risk, EHC is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CHE's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while PACS trades at $42.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas PACS's P/E ratio is 22.49. In terms of profitability, EHC's ROE is +0.25%, compared to PACS's ROE of +0.27%. Regarding short-term risk, EHC is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PACS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while HIMS trades at $27.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas HIMS's P/E ratio is -43.31. In terms of profitability, EHC's ROE is +0.25%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, EHC is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check HIMS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while LHCG trades at $169.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas LHCG's P/E ratio is 82.83. In terms of profitability, EHC's ROE is +0.25%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, EHC is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for EHC.Check LHCG's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while LFST trades at $12.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas LFST's P/E ratio is 95.88. In terms of profitability, EHC's ROE is +0.25%, compared to LFST's ROE of +0.03%. Regarding short-term risk, EHC is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for EHC.Check LFST's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CON trades at $34.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CON's P/E ratio is 21.68. In terms of profitability, EHC's ROE is +0.25%, compared to CON's ROE of +0.47%. Regarding short-term risk, EHC is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CON's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while OPCH trades at $24.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas OPCH's P/E ratio is 14.08. In terms of profitability, EHC's ROE is +0.25%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, EHC is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check OPCH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while NHC trades at $218.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas NHC's P/E ratio is 27.76. In terms of profitability, EHC's ROE is +0.25%, compared to NHC's ROE of +0.13%. Regarding short-term risk, EHC is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for EHC.Check NHC's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AMED trades at $100.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AMED's P/E ratio is 39.30. In terms of profitability, EHC's ROE is +0.25%, compared to AMED's ROE of +0.11%. Regarding short-term risk, EHC is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for EHC.Check AMED's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AVAH trades at $13.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AVAH's P/E ratio is 19.97. In terms of profitability, EHC's ROE is +0.25%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, EHC is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AVAH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while BKD trades at $11.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas BKD's P/E ratio is -20.30. In terms of profitability, EHC's ROE is +0.25%, compared to BKD's ROE of +4.06%. Regarding short-term risk, EHC is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for EHC.Check BKD's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ACHC trades at $28.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ACHC's P/E ratio is 14.14. In terms of profitability, EHC's ROE is +0.25%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, EHC is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ACHC's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while GRDN trades at $40.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas GRDN's P/E ratio is 35.79. In terms of profitability, EHC's ROE is +0.25%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, EHC is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for EHC.Check GRDN's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while MD trades at $27.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas MD's P/E ratio is 12.07. In terms of profitability, EHC's ROE is +0.25%, compared to MD's ROE of +0.20%. Regarding short-term risk, EHC is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for EHC.Check MD's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ADUS trades at $118.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ADUS's P/E ratio is 17.78. In terms of profitability, EHC's ROE is +0.25%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, EHC is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ADUS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while SEM trades at $16.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas SEM's P/E ratio is 15.43. In terms of profitability, EHC's ROE is +0.25%, compared to SEM's ROE of +0.08%. Regarding short-term risk, EHC is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for EHC.Check SEM's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ASTH trades at $38.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ASTH's P/E ratio is 46.35. In terms of profitability, EHC's ROE is +0.25%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, EHC is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ASTH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while SGRY trades at $14.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas SGRY's P/E ratio is 36.56. In terms of profitability, EHC's ROE is +0.25%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, EHC is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SGRY's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AMEH trades at $40.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AMEH's P/E ratio is 39.25. In terms of profitability, EHC's ROE is +0.25%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, EHC is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AMEH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while SNDA trades at $37.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas SNDA's P/E ratio is -6.09. In terms of profitability, EHC's ROE is +0.25%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, EHC is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SNDA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ARDT trades at $10.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ARDT's P/E ratio is 8.79. In terms of profitability, EHC's ROE is +0.25%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, EHC is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ARDT's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while HCSG trades at $21.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas HCSG's P/E ratio is 17.46. In terms of profitability, EHC's ROE is +0.25%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, EHC is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check HCSG's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AGL trades at $88.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AGL's P/E ratio is -5.72. In terms of profitability, EHC's ROE is +0.25%, compared to AGL's ROE of -1.19%. Regarding short-term risk, EHC is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AGL's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while INNV trades at $10.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas INNV's P/E ratio is -119.44. In terms of profitability, EHC's ROE is +0.25%, compared to INNV's ROE of -0.09%. Regarding short-term risk, EHC is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for EHC.Check INNV's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while NUTX trades at $193.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas NUTX's P/E ratio is 7.65. In terms of profitability, EHC's ROE is +0.25%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, EHC is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for EHC.Check NUTX's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while PNTG trades at $38.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas PNTG's P/E ratio is 28.79. In terms of profitability, EHC's ROE is +0.25%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, EHC is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PNTG's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AMN trades at $33.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AMN's P/E ratio is 11.23. In terms of profitability, EHC's ROE is +0.25%, compared to AMN's ROE of +0.15%. Regarding short-term risk, EHC is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AMN's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while BKDT trades at $77.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas BKDT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, EHC is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for EHC.Check BKDT's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while USPH trades at $79.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas USPH's P/E ratio is 31.25. In terms of profitability, EHC's ROE is +0.25%, compared to USPH's ROE of -0.01%. Regarding short-term risk, EHC is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check USPH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TALK trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TALK's P/E ratio is 774.34. In terms of profitability, EHC's ROE is +0.25%, compared to TALK's ROE of +0.00%. Regarding short-term risk, EHC is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TALK's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, GMRS has a market cap of 728.1M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while GMRS trades at $13.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas GMRS's P/E ratio is 5.99. In terms of profitability, EHC's ROE is +0.25%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, EHC is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check GMRS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while EHAB trades at $13.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas EHAB's P/E ratio is -197.14. In terms of profitability, EHC's ROE is +0.25%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, EHC is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for EHC.Check EHAB's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while STLN trades at $5.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas STLN's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to STLN's ROE of +2.10%. Regarding short-term risk, EHC is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for EHC.Check STLN's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TOI trades at $5.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TOI's P/E ratio is -14.25. In terms of profitability, EHC's ROE is +0.25%, compared to TOI's ROE of +2.10%. Regarding short-term risk, EHC is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TOI's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while SRTA trades at $5.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas SRTA's P/E ratio is -25.08. In terms of profitability, EHC's ROE is +0.25%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, EHC is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SRTA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while MCTA trades at $29.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas MCTA's P/E ratio is 419.36. In terms of profitability, EHC's ROE is +0.25%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, EHC is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for EHC.Check MCTA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CYH has a market cap of 406.8M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CYH trades at $2.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CYH's P/E ratio is 3.95. In terms of profitability, EHC's ROE is +0.25%, compared to CYH's ROE of +0.21%. Regarding short-term risk, EHC is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CYH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AUNA has a market cap of 391.6M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AUNA trades at $5.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AUNA's P/E ratio is 4.77. In terms of profitability, EHC's ROE is +0.25%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, EHC is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AUNA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while VMD trades at $9.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas VMD's P/E ratio is 25.22. In terms of profitability, EHC's ROE is +0.25%, compared to VMD's ROE of +0.10%. Regarding short-term risk, EHC is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for EHC.Check VMD's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CSU trades at $33.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CSU's P/E ratio is 0.67. In terms of profitability, EHC's ROE is +0.25%, compared to CSU's ROE of -0.33%. Regarding short-term risk, EHC is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CSU's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AIRS trades at $2.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AIRS's P/E ratio is -93.17. In terms of profitability, EHC's ROE is +0.25%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, EHC is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AIRS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while JYNT trades at $8.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas JYNT's P/E ratio is 83.20. In terms of profitability, EHC's ROE is +0.25%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, EHC is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check JYNT's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while FVE trades at $2.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas FVE's P/E ratio is -5.64. In terms of profitability, EHC's ROE is +0.25%, compared to FVE's ROE of -0.15%. Regarding short-term risk, EHC is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for EHC.Check FVE's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while KDLYW trades at $18.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas KDLYW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, EHC is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check KDLYW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while PARK trades at $20.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas PARK's P/E ratio is 27.61. In terms of profitability, EHC's ROE is +0.25%, compared to PARK's ROE of -0.18%. Regarding short-term risk, EHC is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PARK's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while BTMD trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas BTMD's P/E ratio is 14.05. In terms of profitability, EHC's ROE is +0.25%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, EHC is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for EHC.Check BTMD's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ALR trades at $1.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ALR's P/E ratio is -1.11. In terms of profitability, EHC's ROE is +0.25%, compared to ALR's ROE of -0.15%. Regarding short-term risk, EHC is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ALR's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while DCGO trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas DCGO's P/E ratio is -0.22. In terms of profitability, EHC's ROE is +0.25%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, EHC is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for EHC.Check DCGO's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CCEL trades at $4.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CCEL's P/E ratio is -14.27. In terms of profitability, EHC's ROE is +0.25%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, EHC is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CCEL's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while IMAC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas IMAC's P/E ratio is -2.27. In terms of profitability, EHC's ROE is +0.25%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, EHC is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for EHC.Check IMAC's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while PIII trades at $9.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas PIII's P/E ratio is -0.28. In terms of profitability, EHC's ROE is +0.25%, compared to PIII's ROE of +1.61%. Regarding short-term risk, EHC is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PIII's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, EUDA has a market cap of 25.4M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while EUDA trades at $13.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas EUDA's P/E ratio is -25.66. In terms of profitability, EHC's ROE is +0.25%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, EHC is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check EUDA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while PIIIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas PIIIW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, EHC is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check PIIIW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CANO-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, EHC is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CANO-WT's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AIH trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AIH's P/E ratio is -2.78. In terms of profitability, EHC's ROE is +0.25%, compared to AIH's ROE of +1.16%. Regarding short-term risk, EHC is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AIH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CANO trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CANO's P/E ratio is -0.01. In terms of profitability, EHC's ROE is +0.25%, compared to CANO's ROE of -1.49%. Regarding short-term risk, EHC is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CANO's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while FPCG trades at $1,025.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas FPCG's P/E ratio is 0.09. In terms of profitability, EHC's ROE is +0.25%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, EHC is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for EHC.Check FPCG's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while FTRP trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas FTRP's P/E ratio is -1.22. In terms of profitability, EHC's ROE is +0.25%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, EHC is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for EHC.Check FTRP's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AMS trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AMS's P/E ratio is -5.66. In terms of profitability, EHC's ROE is +0.25%, compared to AMS's ROE of -0.07%. Regarding short-term risk, EHC is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AMS's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while BMGL trades at $4.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas BMGL's P/E ratio is -0.91. In terms of profitability, EHC's ROE is +0.25%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, EHC is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for EHC.Check BMGL's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AIDX trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AIDX's P/E ratio is -1.12. In terms of profitability, EHC's ROE is +0.25%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, EHC is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AIDX's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while MODV trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas MODV's P/E ratio is -0.06. In terms of profitability, EHC's ROE is +0.25%, compared to MODV's ROE of +1.36%. Regarding short-term risk, EHC is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for EHC.Check MODV's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, STLNW has a market cap of 5.5M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while STLNW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas STLNW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, EHC is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for EHC.Check STLNW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while GBNH trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas GBNH's P/E ratio is -0.06. In terms of profitability, EHC's ROE is +0.25%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, EHC is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for EHC.Check GBNH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while RHE-PA trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, EHC's ROE is +0.25%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, EHC is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check RHE-PA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while RHE trades at $2.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas RHE's P/E ratio is -1.79. In terms of profitability, EHC's ROE is +0.25%, compared to RHE's ROE of -1.31%. Regarding short-term risk, EHC is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for EHC.Check RHE's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TOIIW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, EHC's ROE is +0.25%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, EHC is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TOIIW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while IMACW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas IMACW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, EHC is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check IMACW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while EDVA trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas EDVA's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to EDVA's ROE of N/A. Regarding short-term risk, EHC is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for EHC.Check EDVA's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while EUDAW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, EHC's ROE is +0.25%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, EHC is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check EUDAW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while CCM trades at $4.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas CCM's P/E ratio is -0.30. In terms of profitability, EHC's ROE is +0.25%, compared to CCM's ROE of +0.06%. Regarding short-term risk, EHC is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for EHC.Check CCM's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while NIVF trades at $1.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas NIVF's P/E ratio is 0.56. In terms of profitability, EHC's ROE is +0.25%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, EHC is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for EHC.Check NIVF's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, NIVFW has a market cap of 45.5K. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while NIVFW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, EHC's ROE is +0.25%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, EHC is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for EHC.Check NIVFW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while MNDR trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas MNDR's P/E ratio is -0.04. In terms of profitability, EHC's ROE is +0.25%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, EHC is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for EHC.Check MNDR's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TALKW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TALKW's P/E ratio is 0.00. In terms of profitability, EHC's ROE is +0.25%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, EHC is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TALKW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while SLHG trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas SLHG's P/E ratio is -1.48. In terms of profitability, EHC's ROE is +0.25%, compared to SLHG's ROE of N/A. Regarding short-term risk, EHC is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for EHC.Check SLHG's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while SLHGP trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, EHC's ROE is +0.25%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, EHC is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for EHC.Check SLHGP's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while AFAM trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas AFAM's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, EHC is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for EHC.Check AFAM's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TLMD trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TLMD's P/E ratio is -1.60. In terms of profitability, EHC's ROE is +0.25%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, EHC is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TLMD's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while HNGR trades at $18.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas HNGR's P/E ratio is 19.71. In terms of profitability, EHC's ROE is +0.25%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, EHC is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for EHC.Check HNGR's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, NFH has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while NFH trades at $11.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas NFH's P/E ratio is -19.75. In terms of profitability, EHC's ROE is +0.25%, compared to NFH's ROE of -0.06%. Regarding short-term risk, EHC is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for EHC.Check NFH's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while DVCR trades at $10.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas DVCR's P/E ratio is 28.34. In terms of profitability, EHC's ROE is +0.25%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, EHC is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for EHC.Check DVCR's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while ATIP-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, EHC is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for EHC.Check ATIP-WT's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TLMDW trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TLMDW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, EHC is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check TLMDW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while TVTY trades at $32.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas TVTY's P/E ratio is 19.06. In terms of profitability, EHC's ROE is +0.25%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, EHC is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for EHC.Check TVTY's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while DCGOW trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas DCGOW's P/E ratio is N/A. In terms of profitability, EHC's ROE is +0.25%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, EHC is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for EHC.Check DCGOW's competition here

Encompass Health Corporation (NYSE: EHC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EHC stands at 12.1B. In comparison, KND has a market cap of 0. Regarding current trading prices, EHC is priced at $121.79 on the NYSE, while KND trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EHC currently has a P/E ratio of 20.85, whereas KND's P/E ratio is -1.14. In terms of profitability, EHC's ROE is +0.25%, compared to KND's ROE of -0.53%. Regarding short-term risk, EHC is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for EHC.Check KND's competition here